UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

The in silico screening and X-ray structure analysis of the inhibitor complex of Plasmodium falciparum orotidine 5'-monophosphate decarboxylase

Journal of biochemistry (Tokyo), 2012-08, Vol.152 (2), p.133-138

2012

Volltextzugriff (PDF)

Formation of diazoate intermediate upon nitrous acid and nitric oxide treatment of 2′-deoxyadenosine

Bioorganic & medicinal chemistry letters, 2009-02, Vol.19 (3), p.788-791

2009

Volltextzugriff (PDF)

Crystallization and preliminary X-ray diffraction analysis of orotate phosphoribosyltransferase from the human malaria parasite Plasmodium falciparum

Acta crystallographica. Section F, Structural biology and crystallization communications, 2012-02, Vol.68 (2), p.244-246

2012

Volltextzugriff (PDF)

Crystallization and preliminary X-ray diffraction analysis of mouse prostaglandin F 2α synthase, AKR1B3

Acta crystallographica. Section F, Structural biology and crystallization communications, 2011-12, Vol.67 (12), p.1630-1632

2011

Volltextzugriff (PDF)

Crystallization and preliminary X-ray diffraction analysis of mouse prostaglandin F2α synthase, AKR1B3

Acta crystallographica. Section F, Structural biology and crystallization communications, 2011-12, Vol.67 (12), p.1630-1632

2011

Volltextzugriff (PDF)

Irinotecan monotherapy as third-line treatment for advanced gastric cancer refractory to fluoropyrimidines, platinum, and taxanes

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2017-07, Vol.20 (4), p.655-662

2017

Volltextzugriff (PDF)

Impact of Relative Dose Intensity of Early-phase Lenvatinib Treatment on Therapeutic Response in Hepatocellular Carcinoma

Anticancer research, 2019-09, Vol.39 (9), p.5149-5156

2019

Volltextzugriff (PDF)

Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer

Journal of cancer research and clinical oncology, 2016-08, Vol.142 (8), p.1727-1738

2016

Volltextzugriff (PDF)

Randomized Phase III study of 5-fluorouracil continuous infusion vs. sequential methotrexate and 5-fluorouracil therapy in far advanced gastric cancer with peritoneal metastasis (JCOG0106)

Japanese journal of clinical oncology, 2013-10, Vol.43 (10), p.972-980

2013

Volltextzugriff (PDF)

Clinical impact of c‐MET expression and genetic mutational status in colorectal cancer patients after liver resection

Cancer science, 2014-08, Vol.105 (8), p.1002-1007

2014

Volltextzugriff (PDF)

Gastric mucosal injury and hemorrhage after definitive chemoradiotherapy for locally advanced esophageal cancer

Esophagus : official journal of the Japan Esophageal Society, 2019-10, Vol.16 (4), p.402-407

2019

Volltextzugriff (PDF)

Value of KRAS, BRAF, and PIK3CA Mutations and Survival Benefit from Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis

Asian Pacific journal of cancer prevention : APJCP, 2016, Vol.17 (2), p.539-543

2016

Volltextzugriff (PDF)

A retrospective analysis of 5-fluorouracil plus cisplatin as first-line chemotherapy in the recent treatment strategy for patients with metastatic or recurrent esophageal squamous cell carcinoma

International journal of clinical oncology, 2018-06, Vol.23 (3), p.466-472

2018

Volltextzugriff (PDF)

Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer

Journal of cancer research and clinical oncology, 2016-08, Vol.142 (8), p.1727-1738

2016

Volltextzugriff (PDF)

Patterns of Relapse after Definitive Chemoradiotherapy in Stage II/III (Non-T4) Esophageal Squamous Cell Carcinoma

Oncology, 2018-01, Vol.94 (1), p.47-54

2018

Volltextzugriff (PDF)

Determination of Prognostic Factors in Japanese Patients With Advanced Gastric Cancer Using the Data From a Randomized Controlled Trial, Japan Clinical Oncology Group 9912

The oncologist (Dayton, Ohio), 2014-04, Vol.19 (4), p.358-366

2014

Volltextzugriff (PDF)

Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer

BMC research notes, 2014-04, Vol.7 (1), p.271-271, Article 271

2014

Volltextzugriff (PDF)

Pharmacokinetic parameters from 3-Tesla DCE-MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasis

International journal of cancer, 2012-05, Vol.130 (10), p.2359-2365

2012

Volltextzugriff (PDF)

Association between serum ligands and the skin toxicity of anti‐epidermal growth factor receptor antibody in metastatic colorectal cancer

Cancer science, 2015-05, Vol.106 (5), p.604-610

2015

Volltextzugriff (PDF)

Feasibility of neoadjuvant S-1 and oxaliplatin followed by surgery for resectable advanced gastric adenocarcinoma

Surgery today (Tokyo, Japan), 2016-09, Vol.46 (9), p.1076-1082

2016

Volltextzugriff (PDF)

Amplification of FGFR2 Gene in Patients with Advanced Gastric Cancer Receiving Chemotherapy: Prevalence and Prognostic Significance

Anticancer research, 2015-09, Vol.35 (9), p.5055-5061

2015

Volltextzugriff (PDF)

Prognostic role of ERBB2, MET and VEGFA expression in metastatic colorectal cancer patients treated with anti-EGFR antibodies

British journal of cancer, 2016-04, Vol.114 (9), p.1003-1011

2016

Volltextzugriff (PDF)

A phase II study of lenvatinib in patients with metastatic colorectal cancer refractory to standard chemotherapy: LEMON study (NCCH1503)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.3538-3538

2019

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(91)

Publikationsform

Artikel
(93)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Life Sciences & Biomedicine
(48)
Humans
(46)
Male
(43)
Middle Aged
(41)
Female
(40)
Aged
(39)
Oncology
(39)
Adult
(34)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(18)
Chemotherapy
(18)
Cancer Research
(17)
Medicine
(17)
Stomach Neoplasms - Pathology
(17)
Treatment Outcome
(17)
Medicine & Public Health
(16)
Stomach Neoplasms - Drug Therapy
(16)
Gastric Cancer
(15)
Tumors
(15)
Aged, 80 And Over
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The in silico screening and X-ray structure analysis of the inhibitor complex of Plasmodium falciparum orotidine 5'-monophosphate decarboxylase

Formation of diazoate intermediate upon nitrous acid and nitric oxide treatment of 2′-deoxyadenosine

Crystallization and preliminary X-ray diffraction analysis of orotate phosphoribosyltransferase from the human malaria parasite Plasmodium falciparum

Crystallization and preliminary X-ray diffraction analysis of mouse prostaglandin F 2α synthase, AKR1B3

Crystallization and preliminary X-ray diffraction analysis of mouse prostaglandin F2α synthase, AKR1B3

Irinotecan monotherapy as third-line treatment for advanced gastric cancer refractory to fluoropyrimidines, platinum, and taxanes

Impact of Relative Dose Intensity of Early-phase Lenvatinib Treatment on Therapeutic Response in Hepatocellular Carcinoma

Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer

Randomized Phase III study of 5-fluorouracil continuous infusion vs. sequential methotrexate and 5-fluorouracil therapy in far advanced gastric cancer with peritoneal metastasis (JCOG0106)

Clinical impact of c‐MET expression and genetic mutational status in colorectal cancer patients after liver resection

Gastric mucosal injury and hemorrhage after definitive chemoradiotherapy for locally advanced esophageal cancer

Value of KRAS, BRAF, and PIK3CA Mutations and Survival Benefit from Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis

A retrospective analysis of 5-fluorouracil plus cisplatin as first-line chemotherapy in the recent treatment strategy for patients with metastatic or recurrent esophageal squamous cell carcinoma

Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer

Patterns of Relapse after Definitive Chemoradiotherapy in Stage II/III (Non-T4) Esophageal Squamous Cell Carcinoma

Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Analysis

Determination of Prognostic Factors in Japanese Patients With Advanced Gastric Cancer Using the Data From a Randomized Controlled Trial, Japan Clinical Oncology Group 9912

Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer

Pharmacokinetic parameters from 3-Tesla DCE-MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasis

Association between serum ligands and the skin toxicity of anti‐epidermal growth factor receptor antibody in metastatic colorectal cancer

Combination therapy of bevacizumab with either S-1 and irinotecan or mFOLFOX6/CapeOX as first-line treatment of metastatic colorectal cancer (TRICOLORE): Exploratory analysis of RAS status and primary tumour location in a randomised, open-label, phase III, non-inferiority trial

Feasibility of neoadjuvant S-1 and oxaliplatin followed by surgery for resectable advanced gastric adenocarcinoma

Amplification of FGFR2 Gene in Patients with Advanced Gastric Cancer Receiving Chemotherapy: Prevalence and Prognostic Significance

Prognostic role of ERBB2, MET and VEGFA expression in metastatic colorectal cancer patients treated with anti-EGFR antibodies

A phase II study of lenvatinib in patients with metastatic colorectal cancer refractory to standard chemotherapy: LEMON study (NCCH1503)

Suchergebnisse filtern